Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Percutaneous mitral valve repair with the MitraClip system according to the predicted risk by the logistic EuroSCORE: preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry.
Wiebe J, Franke J, Lubos E, Boekstegers P, Schillinger W, Ouarrak T, May AE, Eggebrecht H, Kuck KH, Baldus S, Senges J, Sievert H; German Transcatheter Mitral Valve Interventions (TRAMI) Investigators. Wiebe J, et al. Catheter Cardiovasc Interv. 2014 Oct 1;84(4):591-8. doi: 10.1002/ccd.25493. Epub 2014 Apr 30. Catheter Cardiovasc Interv. 2014. PMID: 24664460
Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.
Hoppmann P, Kufner S, Cassese S, Wiebe J, Schneider S, Pinieck S, Scheler L, Bernlochner I, Joner M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA. Hoppmann P, et al. Among authors: wiebe j. Catheter Cardiovasc Interv. 2016 Apr;87(5):822-9. doi: 10.1002/ccd.26346. Epub 2015 Dec 28. Catheter Cardiovasc Interv. 2016. PMID: 26708019
Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 Trial.
Kufner S, Sorges J, Mehilli J, Cassese S, Repp J, Wiebe J, Lohaus R, Lahmann A, Rheude T, Ibrahim T, Massberg S, Laugwitz KL, Kastrati A, Byrne RA; ISAR-TEST-5 Investigators. Kufner S, et al. Among authors: wiebe j. JACC Cardiovasc Interv. 2016 Apr 25;9(8):784-792. doi: 10.1016/j.jcin.2016.01.009. Epub 2016 Mar 23. JACC Cardiovasc Interv. 2016. PMID: 27017366 Free article. Clinical Trial.
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry.
Wiebe J, Hoppmann P, Kufner S, Harada Y, Colleran R, Michel J, Giacoppo D, Schneider S, Cassese S, Ibrahim T, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA. Wiebe J, et al. EuroIntervention. 2016 Jun 12;12(2):e137-43. doi: 10.4244/EIJY16M05_03. EuroIntervention. 2016. PMID: 27180303 Free article.
Drug-Eluting Balloons or Stents for Bare-Metal Stent Restenosis.
Wiebe J, Colleran R, Kastrati A. Wiebe J, et al. JACC Cardiovasc Interv. 2016 Jun 27;9(12):1256-1258. doi: 10.1016/j.jcin.2016.05.007. Epub 2016 Jun 20. JACC Cardiovasc Interv. 2016. PMID: 27339841 Free article. No abstract available.
Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
Colleran R, Kufner S, Harada Y, Giacoppo D, Cassese S, Repp J, Wiebe J, Lohaus R, Lahmann A, Schneider S, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA; Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5) Investigators. Colleran R, et al. Among authors: wiebe j. Catheter Cardiovasc Interv. 2017 Feb 15;89(3):367-374. doi: 10.1002/ccd.26597. Epub 2016 Jul 5. Catheter Cardiovasc Interv. 2017. PMID: 27377301 Clinical Trial.
306 results